SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19491535
Source:
http://linkedlifedata.com/resource/pubmed/id/19491535
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013227
,
umls-concept:C0043100
,
umls-concept:C0442027
,
umls-concept:C0814225
,
umls-concept:C0935929
,
umls-concept:C1456408
pubmed:issue
3
pubmed:dateCreated
2009-6-3
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00318422
,
http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00318461
pubmed:abstractText
To examine the options for add-on therapy in patients with type 2 diabetes whose disease is no longer adequately controlled by lifestyle interventions and oral antidiabetic drug (OAD)monotherapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401147
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose
,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon-Like Peptide 1
,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/liraglutide
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1941-9260
pubmed:author
pubmed-author:MarreMichelM
,
pubmed-author:NauckMichaelM
pubmed:issnType
Electronic
pubmed:volume
121
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5-15
pubmed:meshHeading
pubmed-meshheading:19491535-Administration, Oral
,
pubmed-meshheading:19491535-Blood Glucose
,
pubmed-meshheading:19491535-Body Weight
,
pubmed-meshheading:19491535-Diabetes Mellitus, Type 2
,
pubmed-meshheading:19491535-Dose-Response Relationship, Drug
,
pubmed-meshheading:19491535-Double-Blind Method
,
pubmed-meshheading:19491535-Drug Therapy, Combination
,
pubmed-meshheading:19491535-Female
,
pubmed-meshheading:19491535-Follow-Up Studies
,
pubmed-meshheading:19491535-Glucagon-Like Peptide 1
,
pubmed-meshheading:19491535-Hemoglobin A, Glycosylated
,
pubmed-meshheading:19491535-Humans
,
pubmed-meshheading:19491535-Hypoglycemic Agents
,
pubmed-meshheading:19491535-Male
,
pubmed-meshheading:19491535-Middle Aged
,
pubmed-meshheading:19491535-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Adding liraglutide to oral antidiabetic drug monotherapy: efficacy and weight benefits.
pubmed:affiliation
Diabeteszentrum, Kirchberg 21, Bad Lauterberg im Harz, Germany. nauck@diabeteszentrum.de
pubmed:publicationType
Journal Article
,
Comparative Study
,
Randomized Controlled Trial
,
Multicenter Study
,
Clinical Trial, Phase II